Sexual Health
CIALIS 20 MG
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 4 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: ELI LILLY
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 4 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: ELI LILLY
CIALIS 20 MG Detailed
Trusted Eli Lilly Cialis 20 mg Source
No reviews found
Please log in to write CIALIS 20 MG review.
Related Offers
US Domestic & International
Kalpa Pharmaceuticals LTD, India
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 20 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 20 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS
Lab Tested
US Domestic & International
Dragon Pharma, Europe
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
55.00 USD
International
Generic
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 60 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: GENERIC
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 60 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: GENERIC
105.00 USD
International
Generic
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 40 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: GENERIC
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 40 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: GENERIC
90.00 USD
International
Generic
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 10 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: GENERIC
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 10 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: GENERIC
84.00 USD